Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Aging Cell|January 26, 2021
Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survivalYeqi Nian, Jasper Iske, Ryoichi Maenosono, et al.
Scientific Reports|June 30, 2022
Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomesRyoichi Maenosono, Tatsuo Fukushima, Daisuke Kobayashi, et al.
Transplantation Proceedings|May 24, 2020
Successful Treatment of Antibody-Mediated Rejection by De Novo Donor Specific Antibody After Primary Renal Transplantation in a Recipient From a Cadaveric Donor: A Case ReportTomohisa Matsunaga, Hajime Hirano, Ryoichi Maenosono, et al.
Clinical Genitourinary Cancer|January 31, 2026
Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell CarcinomaLan Inoki, Shingo Toyoda, Wataru Fukuokaya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 9, 2024
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risksRyoichi Maenosono, Kohei Unagami, Rikako Oki, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 29, 2021
Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashionRyoichi Maenosono, Yeqi Nian, Jasper Iske, et al.
The Prostate|August 2, 2026
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate CancerSaizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto, et al.
Cancer Diagnosis & Prognosis|November 3, 2025
Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell CarcinomaKoichi Sugimoto, Takafumi Minami, Takuhisa Nukaya, et al.
The Prostate|July 27, 2025
Prognostic Impact of Initial Prostate-Specific Antigen in Metastatic Hormone-Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling InhibitorSaizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto, et al.
International Journal of Clinical Oncology|June 11, 2026
Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective studyKoichi Sugimoto, Shingo Toyoda, Lan Inoki, et al.
Pageof 7